Treatment Options for Chronic Diarrhea

Initial Assessment and Classification

• Chronic diarrhea is defined as abnormal passage of ≥3 loose stools per day for more than 4 weeks, according to the European Society of Gastrointestinal Endoscopy 1
• Initial screening should include full blood count, ferritin, tissue transglutaminase/EMA, thyroid function test, and fecal calprotectin, as recommended by the British Society of Gastroenterology 2

First-Line Pharmacological Treatment

• The American Gastroenterological Association recommends loperamide as the first-line treatment for chronic diarrhea, starting with an initial dose of 4 mg followed by 2 mg every 2-4 hours or after every unformed stool, with a maximum daily dose of 16 mg 3
• Other opioids such as tincture of opium, morphine, or codeine may be used if loperamide is ineffective, as suggested by the National Comprehensive Cancer Network 4

Dietary Management

• The European Society for Clinical Nutrition and Metabolism recommends dietary modifications tailored to the underlying cause of chronic diarrhea, including avoiding spices, coffee, alcohol, and reducing insoluble fiber intake 5
• A bland/BRAT (bread, rice, applesauce, toast) diet may be helpful in managing chronic diarrhea, according to the National Comprehensive Cancer Network 6

Cause-Specific Treatments

• The American College of Gastroenterology recommends budesonide 9 mg once daily for refractory cases of inflammatory diarrhea 3
• The European Crohn’s and Colitis Organisation suggests that bile acid sequestrants may be beneficial in treating bile acid malabsorption-related diarrhea 4

Special Considerations

• The Multinational Association of Supportive Care in Cancer recommends rehydration (oral or parenteral) as essential for cancer patients with chronic diarrhea, especially with large-volume diarrhea 7
• The European Society of Medical Oncology advises monitoring for electrolyte imbalances, particularly hypokalemia, in cancer patients with chronic diarrhea 7

Treatment Algorithm

• The American Gastroenterological Association recommends confirming diagnosis and ruling out acute infectious causes before starting symptomatic therapy with loperamide and dietary modifications 8
• The National Comprehensive Cancer Network suggests adding second-line agents (octreotide, bile acid sequestrants, or budesonide) based on suspected mechanism if there is an inadequate response to first-line treatment 4

Common Pitfalls and Caveats

• The European Medicines Agency warns that loperamide overdose can cause serious cardiac adverse reactions, including QT/QTc interval prolongation and arrhythmias, and that empiric antimicrobial use for all diarrheal episodes is not recommended due to increasing drug resistance 8
• The American Heart Association notes that chronic use of stimulant laxatives for constipation can cause diarrhea and hypokalemia, as reported in the journal Gut 9

Chronic Diarrhea Management

Treatment Approach

• The American Gastroenterological Association recommends cholestyramine as the initial therapy of choice for bile acid malabsorption, particularly in patients with prior cholecystectomy, terminal ileal resection, or radiation enteritis 10
• For patients responding to bile acid sequestrants, the American Gastroenterological Association suggests attempting intermittent on-demand dosing rather than continuous daily therapy to minimize adverse events while balancing against high relapse rates 10
• The European Society for Pediatric Gastroenterology, Hepatology and Nutrition recommends a strict lifelong gluten-free diet is mandatory once celiac disease is confirmed by positive serology and duodenal biopsy 11
• The British Society of Gastroenterology recommends that medication review is mandatory, as up to 4% of chronic diarrhea cases are medication-induced, particularly magnesium products, NSAIDs, antibiotics, antihypertensives, and theophyllines 12

Diagnostic Considerations

• The Rome IV criteria have only 52-74% specificity and cannot reliably exclude organic disease, including IBD, microscopic colitis, or bile acid diarrhea, according to the British Society of Gastroenterology 11
• The American Gastroenterological Association recommends always screening for celiac disease and checking fecal calprotectin before labeling as functional 11
• The European Society for Pediatric Gastroenterology, Hepatology and Nutrition suggests testing for HIV in appropriate clinical contexts, as chronic diarrhea is common in newly diagnosed HIV 11

Infectious Causes

• The Centers for Disease Control and Prevention recommends avoiding excessive antimicrobial therapy based on PCR alone without evidence of active toxin production in post-infectious IBS after C. difficile 11
• The Infectious Diseases Society of America notes that one in four patients experience relapse or treatment failure for C. difficile 11

Treatment of Chronic Diarrhea

Initial Diagnostic Workup Required Before Treatment

• The European Society of Gastrointestinal Endoscopy recommends blood tests, including full blood count, ferritin, tissue transglutaminase/EMA, and thyroid function tests to rule out treatable organic causes in patients with chronic diarrhea 13
• The European Society of Gastrointestinal Endoscopy also recommends stool tests, including fecal calprotectin to screen for inflammatory bowel disease in patients with chronic diarrhea 13

First-Line Pharmacological Treatment

• The American Gastroenterological Association recommends loperamide as the first-line pharmacological treatment for chronic diarrhea, which reduces stool frequency and improves consistency without prolonging the disorder 14

Dietary Management

• The National Comprehensive Cancer Network recommends a bland/BRAT diet, including bread, rice, applesauce, and toast, and avoiding fatty foods, heavy meals, spicy foods, caffeine, and alcohol for patients with chronic diarrhea 15
• The American Gastroenterological Association recommends maintaining adequate fluid intake, including glucose-containing drinks or electrolyte-rich soups, for patients with chronic diarrhea 14
• The American Gastroenterological Association also recommends lactose restriction, which may be helpful in prolonged episodes of chronic diarrhea 14

Cause-Specific Treatments

• The National Comprehensive Cancer Network recommends octreotide for persistent grade 2 or grades 3-4 diarrhea not responding to first-line agents, particularly in endocrine tumor-related diarrhea and dumping syndrome 15
• The American Gastroenterological Association recommends budesonide 9 mg once daily for refractory inflammatory diarrhea, particularly if fecal calprotectin is elevated 13

Advanced Therapies for Refractory Cases

• The National Comprehensive Cancer Network recommends anticholinergic agents, including hyoscyamine, atropine, scopolamine, or glycopyrrolate, for grade 2 or higher diarrhea, particularly in end-of-life care settings 15

Treatment Algorithm

• The European Society of Gastrointestinal Endoscopy recommends confirming chronic diarrhea and completing initial screening tests, including blood and stool tests, before initiating treatment 13
• The American Gastroenterological Association recommends seeking medical intervention if there is no improvement in 48 hours, symptoms worsen, or alarm features develop, such as persistent fever, frank blood in stools, severe dehydration, or unintentional weight loss 14

Critical Pitfalls to Avoid

• The American Gastroenterological Association recommends avoiding antimicrobial misuse, reserving antimicrobials for confirmed infectious causes or traveler's diarrhea with dysentery, due to increasing drug resistance 16
• The American Gastroenterological Association also recommends avoiding empirical antimicrobials for chronic diarrhea in developed countries, except for confirmed infectious causes or traveler's diarrhea with dysentery 14

Chronic Diarrhea Management

Diagnostic Evaluation

• The European Society of Gastrointestinal Endoscopy recommends a systematic diagnostic re-evaluation to identify missed treatable causes of chronic diarrhea, including bile acid diarrhea, microscopic colitis, celiac disease, and small intestinal bacterial overgrowth, before escalating to advanced symptomatic therapies 17
• Abnormal full blood count, ferritin, albumin, ESR/CRP results have high specificity for organic disease 17
• Tissue transglutaminase or anti-endomysial antibodies should be tested to rule out celiac disease, which affects 0.5-1% of the population 17
• Vitamin B12, folate, and calcium levels should be checked as indicators of malabsorption 17
• C. difficile testing should be performed, particularly if there is a history of recent antibiotic exposure 17

High-Yield Missed Diagnoses

• Bile Acid Diarrhea (BAD) should be suspected in patients with prior cholecystectomy (68-86% have positive SeHCAT test) 18
• BAD should also be suspected in patients with terminal ileal resection or right hemicolectomy (87-100% positive) 18
• Post-prandial diarrhea that responds to fasting is a characteristic of BAD 17, 19

Medication Review

• Up to 4% of chronic diarrhea cases are medication-induced, and a systematic review of medications should be performed to consider stopping offending agents 17, 19
• Antiarrhythmics can cause medication-induced diarrhea 17

Cause-Specific Treatment Algorithm

• If Bile Acid Diarrhea is suspected or confirmed, first-line treatment is Cholestyramine, starting with 2-4 grams once daily with food 18, 20
• If Cholestyramine is not tolerated, Colesevelam 625 mg, 3-6 tablets daily, or Colestipol can be used as alternative bile acid sequestrants 18
• In Crohn's disease with extensive ileal involvement or resection (>80 cm), bile acid sequestrants are not recommended as they may worsen malabsorption 18, 21, 20

Advanced Symptomatic Management

• If loperamide fails, stronger opioids such as codeine 15-60 mg up to four times daily can be considered 21
• Narcotic bowel syndrome should be monitored for with long-term opioid use 22
• Eluxadoline 100 mg twice daily with food can be used for IBS-D, but is contraindicated in patients without a gallbladder 21

Advanced Interventions

• If all above measures fail and severe malnutrition develops, jejunal feeding via nasojejunal tube or PEGJ, parenteral nutrition, or referral to a specialized motility center for evaluation of severe chronic intestinal dysmotility should be considered 22